Growth Metrics

Organon (OGN) Cash from Financing Activities (2020 - 2026)

Organon has reported Cash from Financing Activities over the past 7 years, most recently at -$38.0 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 49.33% year-over-year to -$38.0 million; the TTM value through Mar 2026 reached -$524.0 million, down 42.01%, while the annual FY2025 figure was -$561.0 million, 52.45% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$38.0 million at Organon, up from -$187.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at -$38.0 million in Q1 2026 and troughed at -$326.0 million in Q1 2023.
  • A 5-year average of -$115.8 million and a median of -$82.0 million in 2022 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 91.85% in 2022 and fell as far as 327.78% in 2022.
  • Year by year, Cash from Financing Activities stood at -$82.0 million in 2022, then increased by 6.1% to -$77.0 million in 2023, then fell by 6.49% to -$82.0 million in 2024, then tumbled by 128.05% to -$187.0 million in 2025, then skyrocketed by 79.68% to -$38.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for OGN at -$38.0 million in Q1 2026, -$187.0 million in Q4 2025, and -$76.0 million in Q3 2025.